| scholarly article | Q13442814 |
| P50 | author | Jonathan Craig | Q38591193 |
| P2093 | author name string | Eknoyan G | |
| Lau J | |||
| Levey AS | |||
| Uhlig K | |||
| Levin A | |||
| Lameire N | |||
| Wanner C | |||
| Walker R | |||
| Steinberg E | |||
| Macleod A | |||
| Moist L | |||
| P2860 | cites work | Grading quality of evidence and strength of recommendations | Q24562409 |
| Publication bias in meta-analysis: its causes and consequences | Q33870662 | ||
| Better reporting of harms in randomized trials: an extension of the CONSORT statement | Q33983100 | ||
| Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors | Q34389549 | ||
| Effect of applying different "levels of evidence" criteria on conclusions of Cochrane reviews of interventions for low back pain | Q35036662 | ||
| Assessing the quality of research | Q35113528 | ||
| The number, quality, and coverage of randomized controlled trials in nephrology. | Q35640724 | ||
| Evidence based? Caveat emptor! | Q46111656 | ||
| Levels of evidence | Q57829789 | ||
| Evidence-based public health: moving beyond randomized trials | Q57951558 | ||
| Clinical trial in nephrology at hard end point? | Q75346741 | ||
| Methods of literature review and synthesis | Q77573710 | ||
| Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi | Q79267289 | ||
| Clinical practice guidelines in nephrology--for worse or for better | Q82744793 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | kidney disease | Q1054718 |
| P304 | page(s) | 2058-2065 | |
| P577 | publication date | 2006-09-27 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). | |
| P478 | volume | 70 |
| Q42982450 | 2011 Japanese Society for Dialysis Therapy Guidelines for the Treatment of Hepatitis C Virus Infection in Dialysis Patients |
| Q90151518 | A Rare Cause of Persistent Blood Loss after Continuous Ambulatory Peritoneal Dialysis Catheter Placement |
| Q79811055 | A call to action on World Kidney Day, 8 March 2007 |
| Q55092256 | Attitudes and Opinions of Canadian Nephrologists Toward Continuous Quality Improvement Options. |
| Q39036126 | Building on evidence to improve patient care |
| Q87041763 | Chapter 2: Methodological approach |
| Q87393467 | Chapter 3: Blood pressure management in CKD ND patients without diabetes mellitus |
| Q34631631 | Chronic kidney disease |
| Q37050341 | Chronic kidney disease perspectives in Japan and the importance of urinalysis screening |
| Q51409315 | Chronic kidney disease prevention—a challenge for Asian countries: report of the Third Asian Forum of Chronic Kidney Disease Initiatives |
| Q43427754 | Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder |
| Q37043279 | Clinical practice recommendations for the care of infants with stage 5 chronic kidney disease (CKD5) |
| Q33752736 | Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2). |
| Q33753500 | Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). |
| Q41863686 | Diagnostic Workup for Disorders of Bone and Mineral Metabolism in Patients with Chronic Kidney Disease in the Era of KDIGO Guidelines |
| Q34206012 | Drug Therapy in Patients With Chronic Renal Failure |
| Q38662074 | Emerging Agents for the Management of Nephrotic Syndrome: Progress to Date |
| Q43556490 | Geographic difference in the prevalence of chronic kidney disease among Japanese screened subjects: Ibaraki versus Okinawa |
| Q33715845 | Guiding principles and checklist for population-based quality metrics. |
| Q42654675 | Hospital acquired Acute Kidney Injury is associated with increased mortality but not increased readmission rates in a UK acute hospital |
| Q49887733 | How to develop Choosing Wisely recommendations for internal medicine |
| Q30595469 | Impact of a modified data capture period on Liu comorbidity index scores in Medicare enrollees initiating chronic dialysis |
| Q37768531 | Implication of global nephrology guidelines in Asia and 'Asian CKD Best Practice Guidelines'. |
| Q50502242 | Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis |
| Q38189525 | KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient |
| Q38652031 | KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors |
| Q39936865 | KDIGO clinical practice guideline for the care of kidney transplant recipients |
| Q39936645 | KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary |
| Q39535980 | KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update |
| Q34659157 | Kidney disease: improving global outcomes |
| Q37403810 | Managing anemia in for-profit dialysis chains: when ethics and business conflict |
| Q87393440 | Methods for guideline development |
| Q87393488 | Methods for guideline development |
| Q87393516 | Methods for guideline development |
| Q87393567 | Methods for guideline development |
| Q87402194 | Methods for guideline development |
| Q33319635 | Nonsurgical treatment of stress urinary incontinence (SUI): grading of evidence in systematic reviews. |
| Q37053437 | Practice guidelines do improve patient outcomes: association or causation? |
| Q36506615 | Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis. |
| Q21257215 | Prevalence of chronic kidney disease in population-based studies: systematic review |
| Q36543071 | Quality Measures for Dialysis: Time for a Balanced Scorecard |
| Q35817018 | Rate of change in renal function and mortality in elderly treated hypertensive patients |
| Q38781507 | Recommendations for kidney disease guideline updating: a report by the KDIGO Methods Committee |
| Q37890249 | Redefining Blood Pressure Targets in High-Risk Patients?: Lessons From Coronary Endpoints in Recent Randomized Clinical Trials |
| Q57945954 | References |
| Q93609057 | References |
| Q93609063 | References |
| Q93609101 | References |
| Q93609219 | References |
| Q84069670 | Renal Association Clinical Practice Guideline Development Policy Manual |
| Q52845698 | Renal Association Clinical Practice Guideline on Peritoneal Dialysis |
| Q84069680 | Renal Association Clinical Practice Guideline on the Assessment of the Potential Kidney Transplant Recipient |
| Q42343473 | Renal association clinical practice guideline in post-operative care in the kidney transplant recipient |
| Q47111895 | Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease |
| Q37323131 | Role of dietary salt and potassium intake in cardiovascular health and disease: a review of the evidence. |
| Q87393326 | Section 1: Introduction and Methodology |
| Q87393329 | Section 2: AKI Definition |
| Q48651768 | Solutions for peritoneal dialysis in children: recommendations by the European Pediatric Dialysis Working Group |
| Q38155411 | Statins in chronic kidney disease: what do meta-analyses tell us? |
| Q38074571 | Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease? |
| Q39454190 | Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors |
| Q53132927 | Summary of the British Transplantation Society/Renal Association UK Guidelines for Living Donor Kidney Transplantation |
| Q49168187 | The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization |
| Q46851869 | The assessment of GFR after orthotopic liver transplantation using cystatin C and creatinine-based equations |
| Q35573682 | The future of European Nephrology 'Guidelines'-a declaration of intent by European Renal Best Practice (ERBP) |
| Q36072666 | The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial |
| Q87156644 | The path to chronic kidney disease following acute kidney injury: a neonatal perspective |
| Q38094888 | Treatment of IgA nephropathy and Henoch–Schönlein nephritis |
| Q38050959 | Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO. |
| Q38050961 | Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. |
| Q84782941 | [KDIGO and DOPPS: what prospects?] |
| Q88188643 | [New KDIGO guidelines on acute kidney injury. Practical recommendations] |
Search more.